Brandywine Global Investment Management »

Silverback Therapeutics shares owned by Brandywine Global Investment Management

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Brandywine Global Investment Management from 13F filings

Historical chart of Brandywine Global Investment Management investment in Silverback Therapeutics

23:59:59.999Sep 29, 202423:59:59.999500:00:00Sep 30, 202400:00:00.000500:00:00.0011.590679M1.5906795M1.59068M1.5906805M1.590681M106.399k106.3995k106.4k106.4005k106.401k
Value ($)Share countHistorical SPRY position of Brandywine Global Investment … Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Brandywine Global Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Brandywine Global Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.6M 106k 14.95

More positions owned by Brandywine Global Investment Management

JPMorgan Chase & Co. (JPM)
Bank of America Corporation (BAC)
Citigroup Com New (C)
Johnson & Johnson (JNJ)
Comcast Corp Cl A (CMCSA)
At&t (T)
General Motors Company (GM)
Wells Fargo & Company (WFC)
Chevron Corporation (CVX)
Kroger (KR)
Abbvie (ABBV)
International Business Machines (IBM)
Caterpillar (CAT)
Delta Air Lines Inc Del Com New (DAL)
Lockheed Martin Corporation (LMT)

View all positions for Brandywine Global Investment Management

Top funds holding Silverback Therapeutics

RA Capital Management
Deerfield Management Company
OrbiMed Advisors
BlackRock
Sr One Capital Management
Alliancebernstein
Vanguard Group
State Street Corporation
Franklin Resources
Alyeska Investment Group
Geode Capital Management
Woodline Partners
Nextech Invest
FMR
Citadel Advisors

View all funds holding Silverback Therapeutics